TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
TCL Archive DCPC Board Kills Cost Sharing for CIS, Rejects Primary Care Prevention Effort Evaluation Budget May 13, 1988
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
